Literature DB >> 21055688

Sinusoidal obstruction syndrome.

Laura Rubbia-Brandt1.   

Abstract

Sinusoidal obstruction syndrome (SOS), formerly named venoocclusive disease, is a well-known complication of hematopoietic stem cell transplantation and ingestion of food or drinks contaminated by pyrrolizidine alkaloids. Many other drugs and toxins have been associated with SOS, including several chemotherapeutic agents and immunosuppressors. SOS contributes to significant morbidity and mortality in all these settings. This review describes the histologic lesions of SOS, details its pathogenesis as it is understood today, specifies the recent data on its causes and how it may influence clinical management of colorectal liver metastases, and discusses the current knowledge on diagnosis and preventive options.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21055688     DOI: 10.1016/j.cld.2010.07.009

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  23 in total

Review 1.  A Critical Analysis of Experimental Animal Models of Sinusoidal Obstruction Syndrome.

Authors:  Arvind Kumar; Richard Palek; Vaclav Liska
Journal:  J Clin Exp Hepatol       Date:  2018-07-17

2.  Patient selection for hepatic resection for metastatic colorectal cancer.

Authors:  Matthew J Weiss; Michael I D'Angelica
Journal:  J Gastrointest Oncol       Date:  2012-03

3.  Sinusoidal obstruction syndrome in the animal model: influence on liver surgery.

Authors:  Azin Jafari; Sven Wehner; Jörg C Kalff; Steffen Manekeller
Journal:  Langenbecks Arch Surg       Date:  2016-09-01       Impact factor: 3.445

4.  Systemic cytotoxic and biological therapies of colorectal liver metastases: expert consensus statement.

Authors:  Roderich E Schwarz; Jordan D Berlin; Heinz J Lenz; Bernard Nordlinger; Laura Rubbia-Brandt; Michael A Choti
Journal:  HPB (Oxford)       Date:  2012-09-24       Impact factor: 3.647

5.  Noninvasive assessment of hepatic sinusoidal obstructive syndrome using acoustic radiation force impulse elastography imaging: A proof-of-concept study in rat models.

Authors:  So Hyun Park; Seung Soo Lee; Ji-Youn Sung; Kiyong Na; Hyoung Jung Kim; So Yeon Kim; Beom Jin Park; Jae Ho Byun
Journal:  Eur Radiol       Date:  2017-12-07       Impact factor: 5.315

6.  Inferior vena cava stenosis-induced sinusoidal obstructive syndrome after living donor liver transplantation.

Authors:  Batsaikhan Bat-Erdene; Sergelen Orgoi; Erdene Sandag; Ulzii-Orshikh Namkhai; Bat-Ireedui Badarch; Batsaikhan Batsuuri
Journal:  Korean J Hepatobiliary Pancreat Surg       Date:  2016-08-29

Review 7.  Morphometric changes and imaging findings of diffuse liver disease in relation to intrahepatic hemodynamics.

Authors:  Kumi Ozaki; Kazuto Kozaka; Yasuo Kosaka; Hirohiko Kimura; Toshifumi Gabata
Journal:  Jpn J Radiol       Date:  2020-04-28       Impact factor: 2.374

Review 8.  Chemotherapy-associated liver injury in patients with colorectal liver metastases: a systematic review and meta-analysis.

Authors:  Stuart M Robinson; Colin H Wilson; Alastair D Burt; Derek M Manas; Steven A White
Journal:  Ann Surg Oncol       Date:  2012-07-06       Impact factor: 5.344

9.  Diagnosing Nodular Regenerative Hyperplasia of the Liver Is Thwarted by Low Interobserver Agreement.

Authors:  Bindia Jharap; Dirk P van Asseldonk; Nanne K H de Boer; Pierre Bedossa; Joachim Diebold; A Mieke Jonker; Emmanuelle Leteurtre; Joanne Verheij; Dominique Wendum; Fritz Wrba; Pieter E Zondervan; Jean-Frédéric Colombel; Walter Reinisch; Chris J J Mulder; Elisabeth Bloemena; Adriaan A van Bodegraven
Journal:  PLoS One       Date:  2015-06-08       Impact factor: 3.240

10.  Glutathione S-transferase M1-null genotype as risk factor for SOS in oxaliplatin-treated patients with metastatic colorectal cancer.

Authors:  C P H Vreuls; S W M Olde Damink; G H Koek; A Winstanley; E Wisse; R H E Cloots; M A J van den Broek; C H C Dejong; F T Bosman; A Driessen
Journal:  Br J Cancer       Date:  2013-01-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.